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ABSTRACT 
 
SAFE AND IMPROVED ANALGESIA FOLLOWING BUPIVACAINE WITH 
EPINEPHRINE INFILTRATION BEFORE SKIN GRAFT HARVESTING 
 
Dr Kong Chee Kwan 
MSurg (Plastic Surgery) 
 
Reconstructive Science Unit, Department of Surgery 
School of Medical Science, Universiti Sains Malaysia 
Health Campus, 16150 Kelantan, Malaysia 
 
Introduction: Skin grafting is the commonest surgical procedure performed 
to cover soft tissue defects.  It has been known that the split skin graft donor site is 
more painful than the recipient site itself.  Despite its frequent usage, the donor site 
preparation and postoperative protocol has not been standardized.  Infiltration of 
lignocaine (or / in addition with bupivacaine) is consistently performed prior to 
harvesting of skin graft only if done under local anaesthesia.  However it is not 
practiced routinely if skin harvesting was done under general anaesthesia.  This 
prospective study determined the benefit and risk of bupivacaine with epinephrine 
infiltration before harvesting skin graft under general anaesthesia. 
 
Method: Sixty patients admitted to University Malaya Medical Centre 
(UMMC) from July 2012 to April 2013 who required split skin graft from thigh as 
part of their management were randomized using online randomization tool into 
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either the infiltration group or no infiltration group.  Post-operatively, all the patients 
were given patient-controlled analgesia (PCA) morphine for at least 24 hours to 
monitor morphine requirement.  The Visual analog scale (VAS) assessment was 
started after 8 hours postoperatively then continued till 24 hours.  Total consumption 
of patient-controlled analgesia morphine was charted every 4 hours to monitor 
consumption of opioid analgesia for breakthrough pain.   
 
Results: Only 53 of the 60 (88.3%) recruited subjects participated in the 
research until completion (27 in the infiltration group while 26 in the no infiltration 
group).  No statistical difference in the distribution between gender, age, ethnic 
group, indication for skin graft and estimated donor size among the two randomized 
groups.  There was significant difference in pain intensity between the two groups 
from 8 to 20 hours post-operatively (p <0.05).  The difference between the two 
groups on cumulative usage of PCA morphine was also significant from 8 to 16 
hours post-operatively.   There was no neuro-cardiotoxicity detected in both group of 
patients.  None of the donor sites was infected and all healed completely by one 
month review. 
 
Conclusion: Subcutaneous infiltration of bupivacaine with epinephrine 
before harvesting of split skin graft under general anaesthesia improved 
postoperative analgesia and decreased opioid consumption.  No sign of any toxicity 
or wound infection observed.  It is a safe procedure in the selected group of patients.  
Therefore, this technique is strongly recommended to be routinely practised to 
improve postoperative care of skin graft patients.  
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ABSTRAK 
 
Graf kulit adalah prosedur pembedahan yang paling biasa dilakukan untuk menutup 
kecederaan tisu lembut.  Telah diketahui bahawa kawasan penderma graf kulit adalah 
lebih sakit daripada tapak penerima itu sendiri.  Walaupun penggunaan yang kerap, 
cara penyediaan tapak penderma dan protokol selepas pembedahan belum 
muktamatkan.  Penyusupan lignocaine (atau / bersama dengan bupivacaine ) secara 
konsisten dilakukan sebelum penuaian graf kulit hanya jika dilakukan di bawah bius 
setempat.  Namun kaedah itu tidak dilakukan secara rutin jika penuaian kulit 
dilakukan di bawah bius am.  Kajian ini bertujuan mengenalpasti faedah dan risiko 
penyusupan bupivacaine dengan epinephrine sebelum penuaian graf kulit di bawah 
bius am. 
 
Enam puluh pesakit yang dimasukkan ke Pusat Perubatan Universiti Malaya (PPUM) 
dari julai 2012 hingga april 2013 yang memerlukan graf kulit dari bahagian paha 
sebagai rawatan diambil sebagai sampel.  Mereka dirambangkan menggunakan alat 
rawak atas talian kepada sama ada kumpulan penyusupan atau kumpulan tanpa 
penyusupan .  Selepas pembedahan, semua pesakit diberi pesakit-kendali-analgesia 
(PCA) morfin untuk sekurang-kurangnya 24 jam untuk memantau keperluan morfin.  
Soal selidik skala visual analog (VAS ) dimulakan selepas 8 jam selepas itu 
kemudian berterusan sehingga 24 jam.  Jumlah penggunaan bagi pesakit yang 
dikendalikan analgesia morfin dicatatkan setiap 4 jam untuk memantau penggunaan 
analgesia opioid. 
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Hanya 53 daripada 60 (88.3 %) pesakit yang dipilih melengkapkan kajian ini (27 
dalam kumpulan penyusupan sedangkan 26 dalam kelompok tanpa penyusupan).  
Tiada perbezaan statistik yang signifikan dalam pengedaran antara jantina, umur, 
kumpulan etnik, indikasi untuk graf kulit dan anggaran saiz penderma di antara 
kedua-dua kumpulan.  Terdapat perbezaan yang signifikan dalam tahap kesakitan 
antara kedua-dua kumpulan pada jam 8 sampai 20 jam selepas pembedahan (p < 
0.05).  Perbezaan di antara kedua-dua kumpulan pada penggunaan kumulatif PCA 
morfin juga signifikan 8-16 jam selepas pembedahan. Tidak ada kesan sampingan 
“neuro” atau “cardiotoxicity” dalam kedua-dua kumpulan pesakit kami. Tiada satu 
pun kulit penderma dijangkiti kuman dan semua sembuh sepenuhnya dalam satu 
bulan susulan. 
 
Penyusupan “subcutaneous bupivacaine” dengan adrenalina sebelum penuaian “skin 
graft” di bawah anestesia am menurunkan tahap kesakitan selepas pembedahan dan 
pengurangkan penggunaan opioid.  Tiada tanda-tanda kesan sampingan atau luka 
jangkitan ditemui.  Kaedah ini adalah selamat dalam kumpulan pesakit kami. Oleh 
yang demikian, teknik ini dianjurkan untuk diamalkan secara rutin untuk menambah 
baik penjagaan pesakit susupan kulit selepas pembedahan. 
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ABSTRACT 
  
Skin grafting is the commonest surgical procedure performed to cover soft tissue 
defects.  It has been known that the split skin graft donor site is more painful than the 
recipient site itself.  Despite its frequent usage, the donor site preparation and 
postoperative protocol has not been standardized.  Infiltration of lignocaine (or / in 
addition with bupivacaine) is consistently performed prior to harvesting of skin graft 
only if done under local anaesthesia.  However it is not practiced routinely if skin 
harvesting was done under general anaesthesia.  This prospective study determined 
the benefit and risk of bupivacaine with epinephrine infiltration before harvesting 
skin graft under general anaesthesia. 
 
Sixty patients admitted to University Malaya Medical Centre (UMMC) from July 
2012 to April 2013 who required split skin graft from thigh as part of their 
management were randomized using online randomization tool into either the 
infiltration group or no infiltration group.  Post-operatively, all the patients were 
given patient-controlled analgesia (PCA) morphine for at least 24 hours to monitor 
morphine requirement.  The Visual analog scale (VAS) assessment was started after 
8 hours postoperatively then continued till 24 hours.  Total consumption of patient-
controlled analgesia morphine was charted every 4 hours to monitor consumption of 
opioid analgesia for breakthrough pain.   
 
Only 53 of the 60 (88.3%) recruited subjects participated in the research until 
completion (27 in the infiltration group while 26 in the no infiltration group).  No 
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statistical difference in the distribution between gender, age, ethnic group, indication 
for skin graft and estimated donor size among the two randomized groups.  There 
was significant difference in pain intensity between the two groups from 8 to 20 
hours post-operatively (p <0.05).  The difference between the two groups on 
cumulative usage of PCA morphine was also significant from 8 to 16 hours post-
operatively.   There was no neuro-cardiotoxicity detected in both group of patients.  
None of the donor sites was infected and all healed completely by one month review. 
 
Subcutaneous infiltration of bupivacaine with epinephrine before harvesting of split 
skin graft under general anaesthesia improved postoperative analgesia and decreased 
opioid consumption.  No sign of any toxicity or wound infection observed.  It is a 
safe procedure in the selected group of patients.  Therefore, this technique is strongly 
recommended to be routinely practised to improve postoperative care of skin graft 
patients.  
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1.  LITERATURE REVIEW 
 
1.1 Introduction 
For soft tissue coverage, split skin grafting is the commonest performed surgical 
procedure.  It is done for wide range of indications, especially for trauma, burn, 
tumour reconstruction and soft tissue infections.  Despite its frequent usage, skin 
graft donor site preparation and postoperative protocol has not been standardized 
(Voineskos S.H., 2009). 
 
It has been known that the split skin graft donor site is more painful than the 
recipient site itself (Alvi R, 1998).  Harvesting of skin graft fires up dermal pain 
receptors in direct relation to the donor size and the pain stimulus are carried to the 
central nervous system by afferent fibres in the cutaneous nerves (Lowrie AG, 
2007). 
 
If the split skin graft donor site is more painful postoperatively than the recipient 
site, then we can predict good graft take (Moriarty Sign) (Oluwatosin OM, 2000). 
Alleviation of this pain can achieve considerable reduction in postoperative distress 
of the patient and encourages early ambulation. Therefore, studies should be 
focused on techniques and materials to reduce post-operative donor site pain. 
 
Opioid analgesics are the medication most commonly used to treat the 
postoperative pain.  However, they are associated with significant undesirable 
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adverse effects such as nausea, vomiting, sedation and constipation.  In their work 
to reduce the adverse consequences of opioids, Blades and Ford introduced the use 
of continuous local anaesthetic infusion in patients having thoracic surgery. They 
found that the supplement of slow, continuous local anaesthetic infusion at the 
surgery site in postoperative patients was associated with less opioids use, shorter 
length of hospital stay, reduced expenses, improved patient satisfaction, and earlier 
return to normal activity (Blades B, 1950). 
 
Although various studies have found that the infiltration of local anaesthetic agent 
combined with epinephrine under donor skin decreases blood loss and pain, it is 
still not widely accepted practice.  The hesitation to adapt this practice stems in part 
from the doubt that infiltrated local anaesthetic agent provides adequate pain relief 
and combined with a fear of its systemic and local side effects (Djurickovic S, 
2001). 
 
Some authors have used and shown that topical anaesthetic agents to be safe when 
delivered as a depot gel(Alvi R, 1998).  It effectively produced an analgesic effect 
that reduced narcotic requirements compared with patients who received 
placebo(Scott, 1999).  There is another research article by Mithat et al in Turkey 
who went all the way to introduce harvesting of split skin graft from insensate flap 
skin as a potential graft donor site for patients in whom reduction of donor site 
morbidity is of primary concern (Mithat Akan, 2002).  
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According to a study done by Trost et al in France, infiltration of split skin grafts 
donor site with ropivacaine after harvesting improves postoperative pain during 48 
hours.  It is a safe and efficient method to improve comfort in addition to a 
standardized occlusive dressing.  This protocol has become a standard routine in the 
author’s institution (Trost, 2005).  
 
Other local anaesthetic agents including short as well as long acting have also been 
reported to reduce pain at split skin graft donor sites.  Cenetoglu et al. used topical 
lignocaine gel at skin graft donor site and found significant pain relief.  However, 
the effect was of shorter duration since lignocaine is a short acting anaesthetic agent 
though its onset of action is early (Cenetoglu S, 2000).  Therefore, in our study, we 
chose bupivacaine over lignocaine because bupivacaine has a longer duration of 
action.  The infiltration of the bupivacaine with epinephrine was done while patient 
was under the effect of general anaesthesia so that the local anaesthetic already 
taken effect before the patient has awakened postoperatively. 
 
Another prospective double blind controlled trial done by Butler et al in Ireland 
studied the differences in post-op pain between sites dressed with a dry calcium 
alginate dressing (Kaltostat®
Butler, 1993
), a saline moistened Kaltostat dressing and a 
bupivacaine (0.5%) moistened Kaltostat dressing.  The study showed there was a 
significant reduction in post-operative pain in the Kaltostat and bupivacaine group 
(p < 0.04).  There was no difference in ease of removal of dressings or the quality 
of wound healing on day 10 between the three groups ( ). 
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A different method introduced to significantly minimize skin graft donor site pain is 
by ice packs directly applied to the donor sites.  The main advantage is its low cost.  
However, this method complicated with leakages in 8 out of 36 of their patients 
(22.2%) requiring total replacement of the dressing (Akan M, 2003). 
 
Some studies have shown bupivacaine to be safe when added to the subcutaneous 
infiltration solution for donor site harvesting.  Fischer CG et al studied 14 patients 
in Cincinnati, Ohio with bupivacaine at a dose of slightly less than 1.9 mg/kg added 
to donor site infiltration.  They concluded that the solution is safe, as demonstrated 
by low blood levels and the absence of clinical signs of toxicity (Fischer CG, 2003). 
 
Both levobupivacaine and ropivacaine have a clinical profile similar to that of 
racemic bupivacaine as studied by Andrea Casati (Andrea Casati, 2005) in Italy.  
The minimal differences observed between the three agents are mainly related to 
the slightly different anaesthetic potency, with racemic bupivacaine > 
levobupivacaine > ropivacaine.  Another consideration is the cost of the chosen 
dose of bupivacaine is about three times lower than the cost of ropivacaine (British 
Medical Association, 2011). This lower cost will have substantial impact on overall 
healthcare cost (Dhalwani, 2012). 
 
Opioid administration is the dominant form of analgesic therapy for burn and post-
operative patients (Ashburn, 1995).  The pharmacokinetics of opioids are altered 
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especially in burn patients, both immediately after the event and for weeks to come 
because of changes in the volume of distribution, unbound drug fraction, clearance 
half-life, and sensitivity.  In addition, opioid requirements may increase over time, 
reaching a ceiling effect, and may not be able to provide complete analgesia all the 
time (Silbert BS, 1991). Therefore, adjuvant treatments are sought to provide 
effective pain relief to such patients and to reduce opioid requirements 
 
The use of lignocaine for tumescent technique liposuction has been commonly used 
for healthy non-burn adults.  Burk RW measured that blood levels of lignocaine 
were below toxic threshold despite high doses (up to 35 mg/kg) in tumescent 
technique liposuction. Burk RW, 1996 ( )  We would like to use a local anaesthetic 
agent which is widely available, long-acting and cost-effective.  Because 
bupivacaine toxicity is a very serious complication, we did not feel the 
extrapolation of the lignocaine data to our patient population was appropriate 
without sufficient safety evidence. Therefore a prospective study was performed to 
assess the benefit and risk of bupivacaine infiltration for skin graft donor site. 
 
To assess the most common dressing for skin graft donor site, a questionnaires 
survey was obtained from 279 British consultant plastic surgeons in 2006.  The 
results showed alginates were the most popular dressings which were the first 
choice for 167 British consultant plastic surgeons (60%).  On the basis of these 
results, the authors felt that any study of donor-site dressings should incorporate the 
most commonly used dressing (alginate) as a control (Geary PM, 2009). 
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1.2 Practice in standard literature 
Infiltration of lignocaine (or/in addition with bupivacaine) is consistently performed 
prior to harvesting of split skin graft only if done under local anaesthesia.  This is 
because the area of skin harvested was small area and it was carried out under local 
anaesthesia.  Usually no routine infiltration if skin harvesting was done under 
general anaesthesia.  Some surgeons do practice infiltrating the donor site with 
local anaesthetic agent after harvesting under general anaesthesia.  Based on our 
anecdotal experience, we have found that those patients given local anaesthetic 
agent were much more comfortable postoperatively.   
 
Although some studies have found that the infiltration of local anaesthetic agent 
and epinephrine under donor skin reduces post-operative pain as well as decreases 
blood loss, it is still not a widely accepted practice.  The hesitation to adapt this 
practice stems in part from the belief that the infiltration will slow blood perfusion 
and, therefore, impairing the healing of these donor sites combined with a fear of 
systemic toxicity (Robertson RD, 2001).  Therefore, this study was initiated to 
objectively assess the benefits of bupivacaine and epinephrine infiltration as well as 
its complications. 
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1.3 Bupivacaine 
Bupivacaine is a local anaesthetic drug belonging to the amino amide group.  It 
binds to sodium channels and blocks sodium influx into nerve cells, which prevents 
depolarization.  The duration of plain bupivacaine is long which is 180 minutes and 
it last even longer up to 420 minutes if combined with epinephrine. 
 
The adverse reactions of bupivacaine due to systemic exposure can be divided into 
cardiovascular and central nervous system effects.  The cardiovascular toxicities are 
hypotension, bradycardia, arrhythmias, and/or cardiac arrest.  The central nervous 
system effects are nervousness, tinnitus, tremor, dizziness, blurred vision, seizures, 
drowsiness, loss of consciousness or respiratory depression (Thorne, 2007). 
 
1.4 Epinephrine (Adrenaline) 
Epinephrine is a hormone and a neurotransmitter. In the body, it is produced only 
by the adrenal glands from the amino acids phenylalanine and tyrosine. It is non-
selective agonist of all adrenergic receptors. The local effect of epinephrine is it 
reduces cutaneous blood flow, thereby decreases bleeding and prolongs the local 
anaesthetic effects (Cartotto R, 2000).  The systemic adverse reactions of 
epinephrine can also be divided into cardiovascular and central nervous systems. 
(Papp AA, 2009). 
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2. OBJECTIVES 
2.1 Research Objectives 
The general objective of this study is to assess the benefits and risk of bupivacaine 
and epinephrine infiltration when given before harvesting of skin graft during 
general anaesthesia 
 
The specific aims of this study are: 
 (1) To assess the difference of pain score when bupivacaine with epinephrine 
infiltration were given pre harvesting of skin graft during general anaesthesia 
(2) To evaluate the reduction of systemic analgesia given to control postoperative 
skin graft pain 
(3) To determine the complication of bupivacaine and epinephrine infiltration 
 
2.2 Research Hypothesis 
(1) Infiltration of bupivacaine and epinephrine pre harvesting of split skin graft 
will result in significant pain relieve in the patient post-operatively 
(2) Usage of systemic analgesia will be reduced following infiltration of 
bupivacaine and epinephrine pre harvesting of split skin graft 
 
2.3 Hypothesized benefits of infiltration 
(1) Reduced post-operative pain 
(2) Reduced usage of systemic analgesia 
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(3) Reduced blood loss 
 
2.4 Potential complications of infiltration 
(1) Cardiac toxicity 
(2) Central nervous system stimulation or depression 
(3) Increasing risk of infection to donor site 
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3. METHODOLOGY 
3.1 Patients and Setting 
Subjects included in our prospective study were selected from patients admitted to 
the University Malaya Medical Centre (UMMC) from July 2012 to April 2013 who 
required split skin graft from thigh under general anaesthesia as part of their 
management.  They were randomized using online randomization tool into either 
the infiltration group or no infiltration group (Randomizer). 
 
The sample size calculation was based on detecting a difference of 0.9 pain score of 
the visual analog scale based on a similar study by Trost O et al using 30 patients 
(Trost, 2005).   By using Power and Sample Size Calculations (Dupont and 
Plummer, Version 3.0), for standard deviation of 1 with 80% power and alpha 0.05, 
we needed 25 patients for each study group.  Anticipated dropout rate was 10%.  
Therefore, total patients recruited were 60. 
 
UMMC research committee has approved the research project (MEC Ref No 
866.4).  Research fund was obtained from UM “Bantuan Kecil Penyelidikan” 
(BK017-2011A).  Written informed consent was obtained from all patients prior to 
surgery.  Patient information sheet and consent forms available in 2 languages 
which are English and Malay languages. 
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The demographic information of the patients was collected, which include: 
(1) Name 
(2) Registration number/Identity card number 
(3) Telephone number 
(4) Gender 
(5) Age 
(6) Ethnic group 
(7) Diagnosis 
(8) Previous surger(ies) 
(Appendix 1) 
 
Inclusion criteria 
• All adult patients (between 12 to 80 years old) undergoing split skin grafting 
• Understanding the nature of the study and willing to complete frequent pain 
assessments via self-reported visual analogue scale score 
• Donor site surface between 100 – 250 cm2 
• Only burn surgery or single procedure (SSG), not combined with other 
procedures 
from thigh region 
• Able to come back for follow-up reviews 
 
Exclusion criteria 
• Patients unable or refused to give consent 
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• Having an alternative source of severe, distracting pain that might down-
score donor-site pain 
• Patients on epidural anaesthesia after surgery 
• Previous history of allergy to bupivacaine or epinephrine 
• Presence of neurological or psychiatric pathology that is likely to affect the 
nociception  
• Known history of cardiac pathology or liver failure 
• Suffering from chronic pain requiring analgesia 
• Uncontrolled diabetes or hypertension with evidence of end-organ damage 
(nephropathy, retinopathy, microvasculopathy) 
• Immunosuppressive disorder 
 
3.2. Statistical Analyses 
Data analysis was performed using the Pearson Chi-Square test for gender, age, 
estimated donor size and indication for skin grafting. The Mann-Whitney U test 
was used to compare pain scores and dosage of patient-controlled analgesia 
morphine utilized.  Statistical analysis was performed with Statistical 
Package for the Social Sciences Windows Version 22.0 (SPSS, 
Chicago, IL, USA). Significance value was taken at less than 0.05. 
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3.3. Materials and Methods 
All of the donor sites were on the thigh.  The area was planned preoperatively as 
shown in Plate 3.1. Area measured was estimated to be about 10-20% bigger than 
expected recipient site. All patients were given intravenous antibiotic prophylaxis 
during induction. 
 
 
Plate 3.1: Marking of donor skin graft site on the thigh 
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Group 1 (study group) – 20ml 0.5% bupivacaine (with 1:200,000 epinephrine) 
diluted with 20ml 0.9% saline (total dose of 100mg bupivacaine and 0.1mg 
epinephrine).  Infiltrated subcutaneously in a circular pattern (field block) 
underneath the pre-marked skin before harvesting the split skin graft as shown in 
Plate 3.2.   
 
 
Plate 3.2: Subcutaneous infiltration of bupivacaine epinephrine  
 
Group 2 (control group) – no infiltration 
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Senior residents performed all skin harvesting procedures.  Skin graft was harvested 
with a Zimmer® Air dermatome at equal thickness on all donor sites (10/1000th
 
 an 
inch) and width 3 inch (Plate 3.3).  Following skin harvesting, topical epinephrine 
solution soaked gauze (1:10,000) were applied for haemostasis. 
 
Plate 3.3: Harvesting of split skin graft 
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Donor skin graft site was then dressed with calcium alginate (Kaltostat®
 
) (Plate 3.4) 
then dry gamzee and crepe bandage. The dressing was keep in situ for 10-14 days. 
Outer layer was changed when it was soaked or dirty. 
 
Plate 3.4: Dressing of donor site with calcium alginate (Kaltostat®
 
) 
Post-operatively, all the patients were given patient-controlled analgesia (PCA) 
morphine for at least 24 hours to monitor morphine requirement.  The Visual 
analog scale (VAS) assessment was started after 8 hours postoperatively then 
continued 4 hourly till 24 hours (Appendix 2).  This is a self-administered tool, well 
validated for research in the field (Lauren JD, 1998).  The VAS pain scale were 
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10cm horizontal line anchored with "no pain" at left-most end and "worse possible 
pain" at right-most end.  The patients were asked to mark the intensity of the pain at 
the donor site, rather than the pain in the recipient site.  It is then converted to 
numerical scale measured from the left-most end. 
 
Total consumption of patient-controlled analgesia morphine was charted every 4 
hours to monitor consumption of opioid analgesia for breakthrough pain.  Clinical 
symptoms or signs of postoperative cardiac or central nervous system toxicity were 
assessed during review. 
 
The donor sites were inspected between days 10 – 14 postoperatively.  If there were 
any signs of inflammation present on donor site, swabs were taken for 
microbiology culture.   Patients were reviewed till complete healing of donor and 
recipient sites (Appendix 3). 
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4. RESULTS 
4.1 Randomization 
A total of 60 patients who underwent split skin graft in University Malaya Medical 
Centre (UMMC) were recruited. All of the patients were randomized using online 
randomization tool (Randomizer) into either the infiltration group or no infiltration 
group. Figure 4.1 show the randomization generated. 
 
 
Figure 4.1: Online randomization generated 
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4.2 Study Population 
Fifty three of the 60 (88.3%) recruited subjects completed the study (27 in the 
infiltration group while 26 in the no infiltration group).  The remaining seven 
patients (11.7%) were excluded because they did not provide the assessments 
completely.  The demographic data of the study population is displayed in Table 
4.1. There were 13 males (n = 13/27) and 14 females (n = 14/27) in the infiltration 
group, and 14 males (n = 14/26) and 12 females (n = 12/26) in the no infiltration 
group.  The difference between the two groups are not significant (p = 0.678) by 
Pearson Chi-Square test. 
 
Table 4.1: Demographic data (p = 0.678) 
 
Gender 
 
Infiltration 
N (%) 
 
 
No infiltration 
N (%) 
 
 
Male 
 
13 (48.1%) 
 
14 (53.8%) 
 
Female 
 
 
14 (51.9%) 
 
12 (46.2%) 
 
Total 
 
 
27 (100%) 
 
26 (100%) 
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4.3 Patient Demography 
Figure 4.2 shows the distribution of the patients according to their age groups.  
Peak age was in the 50-59 age group.  The difference in age of patients recruited for 
the infiltration and no infiltration group was not significant (p = 0. 862). 
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Figure 4.2: Age group of patients (p = 0. 862) 
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4.4 Ethnic Groups 
Majority of our subjects are from ethnic Malay (49.1%), followed by Chinese 
(22.6%), Indian (22.6%) and Indonesian (5.7%).  We have Indonesian patients 
because most of our foreign workers are from Indonesia.  The ethnic distribution of 
our patient among the two groups was not significant (p = 0.458) as shown in 
Figure 4.3. 
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Fig 4.3: Ethnic group of patients (p = 0.458) 
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4.5 Indications for skin graft 
Figure 4.4 illustrates that the majority or 35.8% of the skin grafting were done for 
patients who had burn injury (n = 19/53). The other patients had skin grafts for 
coverage of wounds secondary to trauma (24.5%), tumour (18.9%) or infection 
(20.8%). From T test analysis, there was no statistical difference in the distribution 
of indications between the groups (p = 0.796). 
 
 
 
 
 
 
 
 
  
 
 
 
 
Fig 4.4: Indications for skin grafting (p = 0.796) 
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4.6 Estimated Donor Size 
The donor size harvested was estimated between 116 – 232 cm2.  Majority or 
22.6% of the patient (n = 12/53) had estimated donor size of about 174 cm2
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 as 
shown in Figure 4.5.  There was no statistical difference among the different 
estimated donor sizes between the groups (p = 0.559). 
 
Fig 4.5: Estimated size of skin graft donor site (p = 0.559) 
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4.7 Pain score over 24 hours 
The results of the visual analog score average postoperatively over 24 hours are 
shown in Figure 4.6. The first pain score assessment was done 8 hours 
postoperatively when patient has awakened from anaesthesia and able to provide 
pain assessment. The scores were compared by non-parametric independent 
samples Mann-Whitney U test. There was significant difference in pain intensity 
between the two groups from 8 to 20 hours post-operatively (p <0.05). However, at 
hour 24, it was not significant with p = 0.098. 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.6: Pain score over 24 hours post-surgery 
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